^
Association details:
| Biomarker: | PTPRD mutation |
|---|---|
| Cancer: | Squamous Cell Carcinoma of Head and Neck |
| Drug: | cucurbitacin I (JSI-124) (JAK2 inhibitor, STAT3 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
Excerpt:
Here we demonstrate that HNSCC cells with an endogenous PTPRD mutation are more sensitive to the JAK/STAT inhibitor JSI-124 than HNSCC cells harboring no PTPR family mutations, suggesting that HNSCC tumors with PTPRD mutations may be exquisitely sensitive to STAT3 inhibitors that are currently in preclinical and clinical development.
DOI:
10.1371/journal.pone.0135750
